| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/03/1998 | CA1339694C Human high-affinity neurotranmitter uptake system |
| 03/02/1998 | CA2213690A1 Use of retinoid in preparing a medication to treat disorders related to overexpression of vegf |
| 02/26/1998 | WO1998008101A1 Materials and methods for detection and treatment of immune system dysfunctions |
| 02/26/1998 | WO1998007841A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 02/26/1998 | WO1998007699A1 Propionic acid derivatives and applications thereof |
| 02/26/1998 | WO1998007695A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease |
| 02/26/1998 | WO1998007681A1 Pharmaceutical composition containing 4-oxo-butynic acids |
| 02/26/1998 | WO1998007420A1 Neuropeptide-y ligands |
| 02/26/1998 | CA2268051A1 Neuropeptide-y ligands |
| 02/26/1998 | CA2264220A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease |
| 02/26/1998 | CA2264064A1 Imidazole compounds, compositions and use |
| 02/26/1998 | CA2263721A1 Propionic acid derivatives and applications thereof |
| 02/26/1998 | CA2262817A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 02/26/1998 | CA2259310A1 Materials and methods for detection and treatment of immune system dysfunctions |
| 02/25/1998 | EP0825259A1 Monoclonal antibody reactive with human-origin cetp and method of quantifying human-origin cetp |
| 02/25/1998 | EP0825185A1 Pyridine fused to a bicyclic ring |
| 02/25/1998 | EP0825178A1 Phenyl-substituted alkenoylguanidides, process for their preparation, their use as drugs or in diagnostic agents and drugs containing them |
| 02/25/1998 | EP0824583A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states |
| 02/25/1998 | EP0824546A2 Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/25/1998 | EP0824543A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use |
| 02/25/1998 | EP0824529A1 Benzothiazoles and benzoxazoles, as well as drugs containing them, their use and methods of preparing them |
| 02/25/1998 | EP0824519A1 Beta-adrenergic agonists |
| 02/25/1998 | EP0824357A1 The use of epidermal growth factor as a gastrointestinal therapeutic agent |
| 02/25/1998 | CN1174548A Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 02/25/1998 | CN1174196A Heterocyclic-fused pyridines |
| 02/25/1998 | CN1174032A Compound vitamin drop for infant |
| 02/24/1998 | US5721351 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/24/1998 | US5721276 Treating disorders of melatoninergic system |
| 02/24/1998 | US5721260 Heterocyclic compounds |
| 02/24/1998 | US5721244 Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
| 02/24/1998 | US5721225 Skin disorders; osteoporosis |
| 02/24/1998 | US5721224 Method of treating metabolic bone diseases with 18-nor-vitamin D compounds |
| 02/24/1998 | US5721221 Mixing viscosity-controlled aqueous solutions of hydroxypropyl methyl cellulose into foods |
| 02/24/1998 | US5720977 Oral water soluble pharmaceutical compositions containing estrone compound and calcium salt |
| 02/24/1998 | US5720974 Compression molding mixture of active material, carbohydrate and water |
| 02/24/1998 | US5720304 Diagnosis by conventional medical technique or bi-digital-o-ring test; having patient ingest antibiotic or antiviral agent, also ingest a herb concentration of umbelliferae family over sustained period of time |
| 02/19/1998 | WO1998006867A1 A new method for producing pravastatin precursor, ml-236b |
| 02/19/1998 | WO1998006844A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, kgf-12) |
| 02/19/1998 | WO1998006714A1 Method of producing an extruded nutritional supplement product |
| 02/19/1998 | WO1998006437A2 Compositions and methods for polynucleotide delivery |
| 02/19/1998 | WO1998006423A1 Composition comprising insulin and insulin-like growth factor-i (igf-i) |
| 02/19/1998 | WO1998006418A1 Compositions of plant carbohydrates as dietary supplements |
| 02/19/1998 | WO1998006405A1 Stanol composition and the use thereof |
| 02/19/1998 | WO1997042979A3 Ethene containing solutions and use thereof in methods of therapy or prophylaxis |
| 02/19/1998 | CA2263569A1 Method of producing an extruded nutritional supplement product |
| 02/19/1998 | CA2263143A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12) |
| 02/18/1998 | EP0823912A1 Azacycloalcane derivatives, preparation thereof and their applications in therapy |
| 02/18/1998 | EP0823897A1 Nicotinic acid esters and pharmaceutical compositions containing them |
| 02/18/1998 | EP0823895A1 Fatty acid esters as bioactive compounds |
| 02/18/1998 | EP0823889A1 1,3-propane diol derivatives as bioactive compounds |
| 02/18/1998 | EP0719148B1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt |
| 02/18/1998 | EP0609217B1 Dry starch-iodine pharmaceutical formulations |
| 02/18/1998 | EP0561939B1 Use of angiotensin ii receptor antagonists in the treatment of diabetic nephropathy |
| 02/18/1998 | CN1173815A Liposome formulations of 5'beta' steroids |
| 02/18/1998 | CN1173366A Hypoglycemic high calcium granule and its prodn. |
| 02/17/1998 | US5719303 Phosphonic acid derivatives |
| 02/17/1998 | US5719180 Chroman derivatives having vitamin E-like activities |
| 02/17/1998 | US5719175 Protein kinase C inhibitors |
| 02/17/1998 | US5719173 Administering a benzimidazole carboxylate |
| 02/17/1998 | US5719170 Glucose-6-phosphatase inhibitor; antidiabetic agent |
| 02/17/1998 | US5719169 Substituted benzoylguanidines, their use as a medicament or diagnostic, and medicament containing them |
| 02/17/1998 | US5719160 Method for modifying and regulating lipid metabolism |
| 02/17/1998 | US5719159 4-azasteroids with side-chain fluoroketones |
| 02/17/1998 | US5719143 Polysubstituted 3-acylamino-5-phenyl-1, 4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them |
| 02/17/1998 | CA1339675C Method for the preparation of tetrahydrofolates |
| 02/12/1998 | WO1998005792A2 A novel human leptin receptor gene-related protein |
| 02/12/1998 | WO1998005776A2 Secreted proteins and polynucleotides encoding them |
| 02/12/1998 | WO1998005661A1 Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives |
| 02/12/1998 | WO1998005361A2 Long-acting drugs and pharmaceutical compositions comprising them |
| 02/12/1998 | WO1998005335A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IλB-$g(a) |
| 02/12/1998 | WO1998005333A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 02/12/1998 | WO1998000130A3 Anticonvulsant sulfamate derivatives useful in treating obesity |
| 02/12/1998 | CA2262900A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 02/12/1998 | CA2262399A1 Secreted proteins and polynucleotides encoding them |
| 02/12/1998 | CA2261573A1 A novel human leptin receptor gene-related protein |
| 02/11/1998 | EP0823437A2 8-Substituted B-nor-6-thiaequilenin compounds having activity as selective estrogen receptor modulators |
| 02/11/1998 | EP0822986A1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds |
| 02/11/1998 | EP0822984A1 Human tumor necrosis factor receptors |
| 02/11/1998 | EP0822834A1 Recombinant (beta)-cell and uses thereof |
| 02/11/1998 | EP0822824A1 Method of pretreating viable tissue or cells to be contained within a semipermeable vessel |
| 02/11/1998 | EP0822818A2 Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| 02/11/1998 | EP0822758A1 Supplement for baby infant formula and a method of delivering that supplement |
| 02/11/1998 | EP0776323B1 Salts of an anti-migraine indole derivative |
| 02/11/1998 | EP0624164B1 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 02/11/1998 | CN1173206A Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus |
| 02/11/1998 | CN1173184A Identitication, purification and uses of leczymes and carbohydrate ligands |
| 02/11/1998 | CN1173176A 2 -substituted 1, 2, 5 -thiadiazolidin-3 -one 1, 1-dioxides and compositions and method of use thereof |
| 02/11/1998 | CN1173170A Matrix metalloprotease inhibitors |
| 02/11/1998 | CN1173133A Phosphate-binding polymers for oral administration |
| 02/11/1998 | CN1173132A Dihydropyrimidines and uses thereof |
| 02/11/1998 | CN1172811A Insulin derivatives with increased zinc binding |
| 02/11/1998 | CN1172803A Bicyclic-fused pyridines |
| 02/11/1998 | CN1172801A Fluorinated vitamin D3 analogs |
| 02/11/1998 | CN1172614A Antioxidant composition and method for production thereof |
| 02/11/1998 | CN1037348C Method for preparing substituted 5 -(2 -(2 -(2 -aryl -2 hydroxyethyl) amino) propyl -1, 3 -benzodioxoles amylene |
| 02/10/1998 | US5717102 Psychotherapeutics; headaches |
| 02/10/1998 | US5717070 Culture product |
| 02/10/1998 | US5717062 Cyclic analogs of PTH and PTHrP |
| 02/10/1998 | US5716993 Anthranilic acid derivatives |
| 02/10/1998 | US5716983 Use of coumarins and carbostyrils as PLA2 inhibitors, new coumarins and carbostyrils, processes for the production thereof and pharmaceutical agents |